Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital

by A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina
Published 2015-03-01

BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD

by A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina
Published 2015-06-01

Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia

by I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina
Published 2018-08-01

Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia

by I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina
Published 2018-05-01

Pharmacoeconomic analysis of atezolizumab plus nab-paclitaxel in the treatment of the advanced or metastatic triple-negative breast cancer

by A S Kolbin, I A Vilyum, M A Proskurin, Yu E Balikina, A V Pavlysh
Published 2020-05-01

Social-economic burden of Pompe disease with late onset in the Russian Federation

by A. S. Kolbin, I. A. Vilyum, Yu. E. Balikina, M. A. Proskurin, O. I. Karpov
Published 2019-04-01

Socio-economic burden of chronic migraine in Russia

by A. A. Kolbin, M. V. Naprienko, A. R. Artemenko, I. A. Vilyum, N. V. Latysheva, M. A. Proskurin, Yu. Ye. Balykina
Published 2019-01-01

MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016

by A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum
Published 2016-04-01